Upstream Bio Appoints Allison Ambrose as General Counsel
17. Dezember 2024 08:00 ET
|
Upstream Bio
Upstream appoints Allison Ambrose as General Counsel
Upstream Bio Announces Addition to Russell 2000® Index
16. Dezember 2024 08:00 ET
|
Upstream Bio
Upstream Bio (Nasdaq:UPB) to be added to Russell 2000® index effective at the open of the U.S. equities market on Monday, December 23.
Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference
21. November 2024 08:00 ET
|
Upstream Bio
Upstream Bio CEO to participate in fireside chat at Piper Sandler
COPD and Asthma Devices Market Projected to Reach $44.95 Billion in 2024 with Continued Expansion through 2028, Driven by Technological Innovations and Rising Prevalence - Forecasts to 2033
07. November 2024 09:23 ET
|
Research and Markets
Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) and Asthma Devices Market Report 2024" report has been added to ResearchAndMarkets.com's offering. ...
Acute Respiratory Distress Syndrome Research Report 2024: Market to Grow at a CAGR of 8.7% During 2025-2030, Driven by Technological Advances in Diagnostics and Therapies
23. Oktober 2024 06:28 ET
|
Research and Markets
Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "Global Acute Respiratory Distress Syndrome Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by End-User, Mode of Administration,...
Intelligent Asthma Monitoring Devices Market Research 2024: Partnerships Between Pharma and Smart Inhaler Firms to Revolutionize Asthma Management - Global Long-term Forecasts to 2028 and 2033
17. Oktober 2024 04:01 ET
|
Research and Markets
Dublin, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The "Intelligent Asthma Monitoring Devices Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The intelligent asthma monitoring...
Chronic Obstructive Pulmonary Disease (COPD) Market Forecast Report and Company Analysis 2024-2032 Featuring AstraZeneca, Pfizer, GSK, Novartis, Astellas, Abbott, Boehringer Ingelheim, Almirall
10. September 2024 05:12 ET
|
Research and Markets
Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease, Market Report, Forecast by Types, Treatment Types, Distribution Channels, Countries and Company Analysis,...
United States Pulmonary/Respiratory Diseases KOLs Fair-Market Value Compensation Rates Report: An Independent Reference for Negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs)
10. Juli 2024 05:29 ET
|
Research and Markets
Dublin, July 10, 2024 (GLOBE NEWSWIRE) -- The " Fair-Market Value Compensation Rates for Pulmonary/Respiratory Diseases KOLs - United States" report has been added to ResearchAndMarkets.com's...
Emerging Respiratory Care Companies, 2024: Strategic Profiles and Growth Opportunities to 2028
26. Juni 2024 06:50 ET
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Emerging Respiratory Care Companies: Strategic Profiles and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.This...
Global Cystic Fibrosis Market Report 2024: Growth Amid Rising Prevalence and Innovative Therapeutic Developments - Forecasts to 2029
21. Juni 2024 06:58 ET
|
Research and Markets
Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. Emerging Therapeutics and...